Skip to main content
SpringerLink
Log in

Strategies for Pharmacists in the Implementation of Diabetes Mellitus Management Programs

New Roles in Primary and Collaborative Care

  • Review Article
  • Published:
Disease Management & Health Outcomes

Abstract

Pharmacists are in an ideal position to assess, monitor and treat adherence-related problems that can adversely affect patients’ health outcomes. To accomplish these goals, pharmacists must accept the responsibilities and challenges of a primary care provider. They also must assume an interdisciplinary role in collaborative drug therapy management. Strategies to monitor and improve adherence are key components of pharmaceutical care plans, especially for patients with chronic diseases, such as hypertension, diabetes mellitus and atherosclerotic heart disease.

This article gives an overview of guidelines, recommendations, current practices and related issues in the management of patients with diabetes mellitus. It also reviews the behavioral and social factors that influence adherence to therapeutic and lifestyle regimens, and highlights special needs in selected high-risk populations. Finally, best practice strategies that could serve as appropriate models for pharmaceutical care services are discussed.

The overall goal is to enhance pharmacists’ professional abilities to coordinate pharmaceutical care services targeted for major modifiable behavioral and biological risk factors. Pharmacists can overcome their apprehension about undertaking a primary care role in diabetes management through adequate preparation (including training and certification). The primary care functions that have been evaluated to date in the care of patients with diabetes mellitus by pharmacists show successful patient outcomes in terms of cost, quality of life and reduction of complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Fig. 1

Similar content being viewed by others

References

  1. American Pharmaceutical Association. The pharmacy profession transitioning from prescription providers to health care managers [online]. Available from URL: http://www.pharmacyandyou.org/aboutpharmcarefacts.htm [Accessed 2002 Feb 12].

  2. Schommer JC, Cable GL. Current status of pharmaceutical care practice strategies for education. Am J Pharm Educ 1996; 60: 36–42.

    Google Scholar 

  3. Keeley JL. Position paper. Pharmacists scope of practice. American Society of Internal Medicine. Ann Intern Med 2002; 136 (1): 79–85.

    Google Scholar 

  4. Carmichael JM, O’Connell MB, Devine B, et al. ACCP Position Statement: collaborative drug therapy management by pharmacists. Pharmacotherapy 1997; 17 (5): 1050–61.

    PubMed  CAS  Google Scholar 

  5. Ponte CD. Monitoring diabetes mellitus: the pharmacist’s role. Am Pharm 1992; NS32: 61–5.

    PubMed  CAS  Google Scholar 

  6. Coast-Senior EA, Kroner BA, Kelley CL, et al. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998 Jun; 32 (6): 636–41.

    Article  PubMed  CAS  Google Scholar 

  7. Halapy H, Jaber LA. Diabetes management: follow-up [letter]. Ann Pharmacother 1997 Mar; 31(3): 371.

    PubMed  CAS  Google Scholar 

  8. Jaber LA, Halapy H, Fernet M, et al. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996 Mar; 30 (3): 238–43.

    PubMed  CAS  Google Scholar 

  9. Sadur CN, Moline N, Costa M, et al. Diabetes management in a health maintenance organization: efficacy of care management using cluster visits. Diabetes Care 1999 Dec; 22 (12): 2011–7.

    Article  PubMed  CAS  Google Scholar 

  10. Law AV, Pathak DS, Segraves AM, et al. Cost-effectiveness analyses of the conversion of patients with non-insulin dependent diabetes mellitus from glipizide to glyburide and of the accompanying pharmacy follow-up clinic. Clin Ther 1995; 17: 977–87.

    Article  PubMed  CAS  Google Scholar 

  11. Berringer R, Shibley MC, Cary CC, et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc (Wash) 1999 Nov–Dec; 39 (6): 791–7.

    CAS  Google Scholar 

  12. Wagner EH, Grothaus LC, Sandhu N, et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care 2001 Apr; 24 (4): 695–700.

    Article  PubMed  CAS  Google Scholar 

  13. Skaer TL, Sclar DA, Markowski DJ, et al. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures: a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther 1993; 18: 295–9.

    Article  PubMed  CAS  Google Scholar 

  14. Baran RW, Crumish K, Patterson H, et al. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health Syst Pharm 1999; 56: 1535–9.

    PubMed  CAS  Google Scholar 

  15. Van Amburgh JA, Waite NM, Hobson EH, et al. Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign. Pharmacotherapy 2001; 21 (9): 1115–22.

    Article  PubMed  Google Scholar 

  16. American College of Clinical Pharmacy. ACCP White Paper. Establishing and evaluating clinical pharmacy services in primary care. Pharmacotherapy 1994; 14 (6): 743–58.

    Google Scholar 

  17. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO Consultation, Part I. Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999.

    Google Scholar 

  18. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21 (9): 1414–31.

    Article  PubMed  CAS  Google Scholar 

  19. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemic of obesity and diabetes in the United States. JAMA 2001 Sep 12; 286 (10): 1195–200.

    Article  PubMed  CAS  Google Scholar 

  20. Troiano RP, Flegal KM, Kuczmarski RJ, et al. Overweight prevalence and trends for children and adolescents: the National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med 1995; 149 (10): 1085–91.

    Article  PubMed  CAS  Google Scholar 

  21. Ramachandran A, Snehalatha C, Vijay V, et al. Impact of poverty on the prevalence of diabetes and its complications in urban southern India. Diabet Med 2002; 19 (2): 130–5.

    Article  PubMed  CAS  Google Scholar 

  22. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998; 21 (2): 296–309.

    Article  Google Scholar 

  23. Health Promotion Branch-Laboratory Centre for Disease Control. Diabetes in Canada highlights. Available from URL: http://www.hc-sc.gc.ca/hpb/lcdc/publicat/diabet99/d02_e.html. [Accessed 2002 Oct 22].

  24. WHO Information Fact Sheets. Facts sheet No.138. Revised 2002 Apr. Geneva: World Health Organization. Available from URL: http://www.who.int/inf-fs/en/fact138.html. [Accessed 2002 Oct 29].

  25. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2002; 25: 213–29.

    Article  Google Scholar 

  26. US Department of Health and Human Services, Center for Disease Control and Prevention. National Diabetes Fact Sheet. 1998. Available from URL: http://www.cdc.gov/diabetes/pubs/facts98.htm#types [Accessed 2002 Oct 31].

  27. Kuzuya T, Malsuda A. Classification of diabetes on the basis of etiologies versus degree of insulin deficiency. Diabetes Care 1997; 20: 219–20.

    PubMed  CAS  Google Scholar 

  28. Zimmet PZ. The pathogenesis and prevention of diabetes in adults. Diabetes Care 1995; 16: 1050–64.

    Google Scholar 

  29. Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin resistance syndrome (Syndrome X). Diabetes 1992; 41: 715–22.

    Article  PubMed  CAS  Google Scholar 

  30. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317 (7160): 707–13.

    Google Scholar 

  31. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103–17.

    Article  PubMed  CAS  Google Scholar 

  32. Florence JA, yeager BF. Treatment of type 2 diabetes mellitus. Am Fam Phys [online] 1999 May 15. Available from http://www.aafp.org/afp.990515ap/2835.html [Accessed 2002 Nov 11].

  33. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics fact sheet: general information and national estimates on diabetes in the United States, 2000. Bethesda (MD): U.S. Department of Health and Human Services, National Institutes of Health, 2002.

  34. Diabetes Control and Complications Trial Research Group (DCCT). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.

    Article  Google Scholar 

  35. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346 (6): 393–403.

    Article  PubMed  CAS  Google Scholar 

  36. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyles among subjects with impaired glucose tolerance. N Engl J Med 2001 May 3; 344 (18): 1343–50.

    Article  PubMed  CAS  Google Scholar 

  37. National standards for diabetes self-management education. Diabetes Care 2002; 25(1): S140–7.

    Article  Google Scholar 

  38. European Diabetes Policy Group. Desktop guide to type 1 diabetes. International Diabetes Federation (European region, Brussels). Available from URL: http://www.staff.ncl.ac.uk/philip.home/guidelines [Accessed 2002 Nov 7].

  39. European Diabetes Policy Group. Desktop guide to type 2 diabetes [online]. International Diabetes Federation (European region, Brussels). Available from URL: http://www.staff.nci.ac.uk/philip.home/guidelines [Accessed 2002 Nov 7].

  40. Kriska J, Cromarty JA, Arris F, et al. Providing pharmaceutical care using a systematic approach. Pharmaceut J 2000; 265 (7120): 656–60.

    Google Scholar 

  41. Dunbar, JM, Stunkard AJ. Adherence to diet and drug regimen. In: Dennis B, Ernst N, editors. Nutrition, lipids and coronary heart disease. New York (NY): Raven Press, 1994: 391–423.

    Google Scholar 

  42. Nichols-English GJ, Poirier S. Optimizing adherence through pharmaceutical care plans. J Am Pharm Assoc 2000; 40 (4): 475–85.

    CAS  Google Scholar 

  43. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US Adults, NHANES III, 1988–94. Diabetes Care 1998; 21 (4): 518–24.

    Article  PubMed  CAS  Google Scholar 

  44. Jacobson AM. The psychological care of patients with insulin-dependent diabetes mellitus. N Engl J Med 1996; 334: 1249–53.

    Article  PubMed  CAS  Google Scholar 

  45. Jacobson AM, Adler AG, Derby L, et al. Clinic attendance and glycemic control: study of contrasting groups of patients with IDDM. Diabetes Care 1991; 14: 599–601.

    Article  PubMed  CAS  Google Scholar 

  46. McGill JB, Lustman PJ, Griffith LS, et al. Relationship of depression to compliance with self-monitoring of blood glucose [abstract]. Diabetes 1992; 41: A84.

    Google Scholar 

  47. Littlefield CH, Craven JL, Rodin GM, et al. Relationship of self-efficacy and binging to adherence to diabetes regimen among adolescents. Diabetes Care 1992; 15: 90–4.

    Article  PubMed  CAS  Google Scholar 

  48. Garner DM, Garfinkel PE. The eating attitudes test: an index of the symptoms of anorexia nervosa. Psychol Med 1979; 9: 273–9.

    Article  PubMed  CAS  Google Scholar 

  49. Rodin GM, Daneman D. Eating disorders and IDDM: a problematic association. Diabetes Care 1992; 15: 1402–12.

    Article  PubMed  CAS  Google Scholar 

  50. Diabetes Control and Complications Trial Research Group. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988; 11: 725–32.

    Article  Google Scholar 

  51. Polonsky WH, Anderson BJ, Lohrer PA, et al. Insulin omission in women with IDDM. Diabetes Care 1994; 17: 1178–85.

    Article  PubMed  CAS  Google Scholar 

  52. Nattrass M. The theory of treating type 2 diabetes. Int J Obes Relat Metab Disord; 2000; 24 Suppl. 3: S2–5.

    Article  PubMed  Google Scholar 

  53. National Diabetes Data Group. Diabetes in America. 2nd ed. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995. Report No.: NIH Publication No. 95–1468. Available from URL: http://www.diabetes-in-america.s-3.com/default.htm [Accessed 2002 Oct 30].

  54. Kozma CM, Reeder CE, Schulz RM. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 1993; 15: 1121–39.

    PubMed  CAS  Google Scholar 

  55. Munroe WP, Kunz K, Dalmady-Israel C, et al. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997; 19: 113–23.

    Article  PubMed  CAS  Google Scholar 

  56. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother 1999; 33: 1336–55.

    Article  PubMed  CAS  Google Scholar 

  57. Montazeri M, Cook DJ. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 1994; 22: 1044–8.

    Article  PubMed  CAS  Google Scholar 

  58. Aucot JN, Pelecanos E, Dombrowski R, et al. Implementation of local guidelines for cost-effective management of hypertension. J Gen Intern Med 1996; 11: 139–46.

    Article  Google Scholar 

  59. Jillmarie KY. Implementation of a drug therapy monitoring clinic in a primarycare setting. Am J Health Syst Pharm 2000; 57 Suppl. 4: S30–4.

    Google Scholar 

  60. Lehmann DF, Medicis JJ. A pharmacoeconomic model to aid in the allocation of ambulatory clinical pharmacy services. J Clin Pharmacol 1998; 38: 783–91.

    PubMed  CAS  Google Scholar 

  61. American Pharmaceutical Association. Principles of practice for pharmaceutical care. American Pharmaceutical Association, Washington, DC [online]. Available from URL: http://www.aphanet.org/pharmcare/prinprac.html [Accessed 2002 Nov 8].

  62. American Association of Diabetes Educators. The scope of practice for diabetes educators and the standards of practice for diabetes educators. Diabetes Educ 2000; 26: 25–31.

    Article  Google Scholar 

  63. Disease State Management (DSM) Credentialing for Pharmacists. National Institute for Standards in Pharmacist Credentialing (NISPC). Available from URL: http://www.ncpanet.org/EDUCATION/nispc.html. [Accessed 2002 Feb 26].

  64. Jenkins D. An integrated behavioral medicine approach to improving care of patients with diabetes mellitus. Behav Med 1995; 21: 53–64.

    Article  PubMed  CAS  Google Scholar 

  65. Bandura A. Social learning theory. Englewood Cliffs (NJ): Prentice-Hall, 1977.

    Google Scholar 

  66. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking toward an integrative model of change. J Consult Clin Psychol 1983; 51: 390–5.

    Article  PubMed  CAS  Google Scholar 

  67. Prochaska JO, Velicer WF, Guadagnoli E, et al. Patterns of change: dynamic typology applied to smoking cessation. Multivariate Behav Res 1991; 26: 83–107.

    Article  Google Scholar 

  68. Wierenga ME. Life-style modification for weight control to improve diabetes health status. Patient Educ Couns 1994; 23: 33–40.

    PubMed  CAS  Google Scholar 

  69. Hsaio LCD, Salmon JW. Predicting adherence to prescription medication purchase among HMO enrollees with diabetes. J Managed Care Pharm 1999; 5 (4): 336–41.

    Google Scholar 

  70. McCallian DJ, Carlstedt BC, Rupp M. Elements of a pharmaceutical care plan. J Am Pharm Assoc 1999; 39 (1): 81–3.

    Google Scholar 

  71. Felkey BG. Adherence screening and monitoring. Am Pharm 1995; NS35: 42–51.

    PubMed  CAS  Google Scholar 

  72. American Diabetes Association. Facilitating lifestyle change: a resource manual. Alexandria (VA): American Diabetes Association, 1999.

    Google Scholar 

  73. Brown SA. Studies of educational interventions and outcomes in diabetic adults: meta-analysis revisited. Patient Educ Couns 1990; 16: 189–215.

    Article  PubMed  CAS  Google Scholar 

  74. Glasgow RE, McCaul KD, Shafer LC. Barriers to regimen adherence among persons with insulin-dependent diabetes. J Behav Med 1986; 9 (1): 65–77.

    Article  PubMed  CAS  Google Scholar 

  75. Brownlee-Duffeck M, Peterson L, Simonds JF, et al. The role of health beliefs in the regimen adherence and metabolic control of adolescents and adults with diabetes mellitus. J Consult Clin Psychol 1987; 55: 139–44.

    Article  PubMed  CAS  Google Scholar 

  76. Brown SA, Garcia AA, Kouzekanani K, et al. Culturally competent diabetes self-management education for Mexican Americans: the Starr County Border Health Initiative. Diabetes Care 2002 Feb; 25 (2): 259–68.

    Article  PubMed  Google Scholar 

  77. Agras WS. Adherence intervention research: the need for a multilevel approach. In: Krasnegor NA, Epstein L, Johnson SB, et al., editors. Developmental aspects of health compliance behavior. Hillsdale (NJ): Lawrence Erlbaum Associates, 1993: 285–301.

    Google Scholar 

  78. Bott U, Jorgens V, Grusser M, et al. Predictors of glycemic control in type 1 diabetic patients after participation in an intensified treatment and teaching program. Diabet Med 1994; 11: 362–71.

    Article  PubMed  CAS  Google Scholar 

  79. Cohen M, Zimmer P. Self monitoring of blood glucose levels in non-insulin-dependent diabetes mellitus. Med J 1983; 2: 377–80.

    CAS  Google Scholar 

  80. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Adult and Community Health, data from the Behavioral Risk Factor Surveillance System. Data computed by the Division of Diabetes Translation. Available from URL: http://www.cdc.gov/diabetes/statistics/survl99/chap10/fig1.htm. [Accessed 2002 May 8].

  81. Huff PS, Ives TJ, Almond SN, et al. Pharmacist-managed diabetes education service. Am J Hosp Pharm 1983; 40: 991–4.

    PubMed  CAS  Google Scholar 

  82. The cost of diabetes fact sheet [online]. Available from URL: http://www.who.int/inf-fs/en/fact236.html [Accessed 2002 Oct 31].

  83. Ordre des Pharmaciens du Québec. Code Médicament [Caution Drug Code]. Available from URL: http://www.opq.org/fr/code_medicament/default.htm [Accessed 2002 Mar 18].

  84. Mendenhall M. Green means caution in MB and SK. August 1999. Available from URL: http://www.pharmacyconnects.com/content/phpost/1999/08-99/ppo. [Accessed 2002 Jun 13].

  85. New concept in primary care pharmacy could be model for future practice [News summary]. Pharmaceut J 2001 Jul; 267 (7155): 3–8.

  86. Elliott WJ, Maddy R, Toto R, et al. Hypertension in patients with diabetes: overcoming barriers to effective control. Post Grad Med 2000; 107 (3): 29–38.

    CAS  Google Scholar 

  87. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339 (37): 1957–63.

    Article  PubMed  CAS  Google Scholar 

  88. Segal R. Applying the principles of pharmaceutical care to the patient with diabetes. Pharm Pract Manage Q 1997; 17 (2): 47–53.

    CAS  Google Scholar 

  89. Piwernetz K. DIABCARE Quality Network in Europe: a model for quality management in chronic diseases. Int Clin Psychopharmacol 2001 Apr; 16 Suppl. 3: S5–13.

  90. Lehmann ED. Experience with the Internet release of AIDA v4.0. Available from URL: http://www.diabetic.org.uk/aida.htm: an interactive educational diabetes simulator. Diabetes Technol Ther 1999 Spr; 1 (1): 41–54.

    Article  PubMed  CAS  Google Scholar 

  91. Lehmann ED. Database program for use with blood glucose meters. Diabetes Technol Ther 1999; 1 (3): 391–3.

    Article  PubMed  CAS  Google Scholar 

  92. Edlin M. Rally the troops before you tackle diabetes: collaboration between the patient, physician and health plan is easier and more effective with internet tools. Manage Health Care 2000 May; 10 (5): 47–9.

    Google Scholar 

  93. Gillespie G. Deploying an IT cure for chronic diseases. Health Data Manage 2000 Jul; 8 (7): 68–74.

    CAS  Google Scholar 

  94. Patrick TB, Monga HK, Sievert ME, et al. Evaluation of controlled vocabulary resources for development of a consumer entry vocabulary for diabetes. J Med Internet Res [online journal] 2001; 3 (3): e24. Available from URL: http://www.jmir.Org/2001/3/e24/.

    Article  CAS  Google Scholar 

  95. Donabedian A. The quality of care: how can it be assessed? JAMA 1988; 260: 1743–8.

    Article  PubMed  CAS  Google Scholar 

  96. Nichols GA, Brown JB. The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care 2002; 25 (3): 482–6.

    Article  PubMed  Google Scholar 

  97. Caro JJ, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the US. Diabetes Care 2002; 25 (3): 476–81.

    Article  PubMed  Google Scholar 

  98. Poirier S. Reimbursement for cognitive services: Quebec’s experience. Am Pharm 1992; NS32(5): 56–60.

    PubMed  CAS  Google Scholar 

  99. Health Protection Branch-Laboratory Centre for Disease Control. Diabetes in Canada: Morbidity. Available from URL: http://www.hc-sc.gc.ca/hpb/lcdc/publicat/diabet99/d06_e.html [Accessed 2002 Jun 8].

Download references

Acknowledgements

The authors declare no sources of funding or conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Department of Clinical and Administrative Sciences, College of Pharmacy, University of Georgia, Athens, Georgia, USA

    Gloria J. Nichols-English (Assistant Professor), Melanie Provost, Dayin Koompalum & Hua Chen

  2. Stephenson County Health Department, Freeport, Illinois, USA

    Masood Athar

Authors
  1. Gloria J. Nichols-English
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Melanie Provost
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dayin Koompalum
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hua Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masood Athar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gloria J. Nichols-English.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nichols-English, G.J., Provost, M., Koompalum, D. et al. Strategies for Pharmacists in the Implementation of Diabetes Mellitus Management Programs. Dis-Manage-Health-Outcomes 10, 783–803 (2002). https://doi.org/10.2165/00115677-200210120-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200210120-00005

Keywords

Search

Navigation